# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006992
Filing Date
2021-05-13
Accepted
2021-05-13 07:30:49
Documents
62
Period of Report
2021-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | akro-20210331x10q.htm | 10-Q | 1330983
2 | EX-31.1 | akro-20210331ex311f44f41.htm | EX-31.1 | 10732
3 | EX-31.2 | akro-20210331ex3125c8d59.htm | EX-31.2 | 11640
4 | EX-32.1 | akro-20210331ex3213f7e66.htm | EX-32.1 | 10471
| Complete submission text file | 0001558370-21-006992.txt |  | 5160142

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.INS | akro-20210331.xml | EX-101.INS | 1051949
6 | EX-101.SCH | akro-20210331.xsd | EX-101.SCH | 40217
7 | EX-101.CAL | akro-20210331_cal.xml | EX-101.CAL | 36169
8 | EX-101.DEF | akro-20210331_def.xml | EX-101.DEF | 101142
9 | EX-101.LAB | akro-20210331_lab.xml | EX-101.LAB | 383034
10 | EX-101.PRE | akro-20210331_pre.xml | EX-101.PRE | 271156

Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38944 | Film No.: 21917205
SIC: 2834 Pharmaceutical Preparations